PF-06291874

· Pfizer

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PF-06291874, covering 2012-01-31 to 2018-11-01. Get the full timeline:

Most recent: Clinical Trial Update: PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients [Phase 1]